SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001659617-20-000138
Filing Date
2020-05-27
Accepted
2020-05-27 17:20:43
Documents
4
Period of Report
2020-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kmoleculinprovidesup.htm 8-K 22684
2 EXHIBIT 99.1 exh991-pressreleasemolecul.htm EX-99.1 18748
3 moleculin-logo_horiza45.jpg GRAPHIC 132868
4 moleculinlogoa47.jpg GRAPHIC 11658
  Complete submission text file 0001659617-20-000138.txt   231228
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 20916271
SIC: 2834 Pharmaceutical Preparations